Multiple Sclerosis Research Update – December 2020 MStranslate December 15, 2020 Progressive MS, Research, Stem Cells, Treatments With the end of 2020 approaching (I don’t think anyone is going to miss it), we thought we would try out a new style of research update. Generally, our articles are an in-depth look at a specific study...
MS Research in the New Millennium: 2000 – 2020 MStranslate July 23, 2020 Research, Treatments It’s been 20 years since the world nervously welcomed the new millennium. Let’s look back on those two decades and examine the major developments in Multiple Sclerosis research and treatment. Twenty...
Bile Acids May Play Role in Multiple Sclerosis MStranslate June 23, 2020 Research, Treatments 1 Comment Research Summary: Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation A joint investigation undertaken by researchers at Johns Hopkins University, the...
Fruit Peel Compound Shows Treatment Potential MStranslate April 7, 2020 Research, Treatments Research Summary: A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination A newly published study in the highly respected medical journal,...
Mesenchymal Stem Cell Trial for Multiple Sclerosis MStranslate February 2, 2020 Conferences, Dr Travis Stiles, ECTRIMS, Stem Cells, Treatments EXCLUSIVE INTERVIEW At ECTRIMS Congress 2019, we had the privilege of interviewing Prof. Dimitrios Karussis (Neurologist, Hadassah Hospital) about the exciting results from his mesenchymal stem cell trial...
BEAT-MS Trial to Compare AHSCT to MS Treatments MStranslate January 14, 2020 Research, Stem Cells, Treatments Over recent years, we have seen a large expansion in the number of available treatments for people living with relapsing-remitting multiple sclerosis (RRMS). As well as this, we have recently seen a number...
Research Reflections: Siponimod Trial Results MStranslate November 21, 2019 Clinical Trials, Research, Treatments 1 Comment In April 2018, we published the below video to our Facebook page, exploring and discussing the results of the Phase III trial of Mayzent (siponimod). With this therapy recently approved for the treatment of...
Treatment With Gut Bacteria Shows Benefits In New Study MStranslate May 2, 2019 Research, Treatments 1 Comment Research Summary: Prevotella histicola, A Human Gut Commensal, Is as Potent as COPAXONE® in an Animal Model of Multiple Sclerosis Many people living with multiple sclerosis say they have experienced...
FDA Approves Second Drug For Active SPMS MStranslate April 1, 2019 Research, Treatments Late last week, it was announced that Mavenclad (cladribine) received US FDA approval for the treatment of adults living with relapsing multiple sclerosis (MS). Importantly, this also includes people living...
New Treatment Approved for Active SPMS MStranslate March 27, 2019 Research, Treatments 1 Comment It was announced earlier today that Mayzent (siponimod) has received US FDA approval for the treatment of adults living with relapsing multiple sclerosis (MS). Importantly, this also includes people living...